What we do Amwill Health Care Ltd develops and manufactures dermatological and derma-cosmetic products, offering solutions for various skin disorders through contract manufacturing and proprietary formulations. |
Founded in 2,017 |
Market share Emerging player focusing on dermatological solutions with growing product portfolio and structured distribution. |
Problem solved Providing effective, scientifically developed solutions for dermatological disorders. |
Top clients or who we serve B2B and B2C customers in dermatology and cosmetic sectors. |
Key management Anand Gandhi, Managing Director (Master's in Pharmacy, 10+ years in dermatology marketing); Tarun Gandhi, Chairman and Managing Director (Commerce background, 10+ years in finance and business development). |
Our journey and innovations Started in 2017, transferred promoter’s IP rights in 2021, launched key products XL-HYDRA and Fin-XL Pro Gel, formalized supply chain via Amderma Healthcare LLP. |
Where we operate India, primarily Karnataka with expanding distribution network. |
Top products or what we offer Dermatological creams, face moisturizers like XL-HYDRA, hair care gels such as Fin-XL Pro Gel, contract manufacturing dermatological formulations. |
Top brands XL-HYDRA (face moisturizer), Fin-XL Pro Gel (hair therapy gel) |
Raw materials needed Active pharmaceutical ingredients and derma-cosmetic raw materials. |
Raw materials supplier - |
Recurring vs cyclical contribution Revenue primarily from product sales, with recurring contract manufacturing orders developing. |
Our industry position Niche dermatological product developer with growing market footprint in India. |
Financial highlights FY 2023-24 Revenue Rs 40.58 Cr, Net Profit Rs 10.73 Cr, demonstrating healthy profitability and growth trajectory. |
Geographical revenue split - |
Order book - |
Whats driving growth Innovation in dermatological formulations, strengthening distribution, and formalizing operations post-IP transfer. |
Our future plans Expanding product range, enhancing manufacturing capacity, and increasing market penetration post IPO. |
Our green promise - |
Our people and values Driven by a team of experienced promoters and professionals emphasizing quality and innovation. |
Key challenges ahead Scaling manufacturing, competition in dermatology market, and building brand recognition. |
Interesting facts Promoter-developed products predate the company; formal IPO in 2025 to scale operations. |
Risks and strategy Mitigating regulatory, market, and supply risks through diversification and compliance. |
